Daubert v. Merrell Dow Pharmaceuticals, Inc.

Daubert v. Merrell Dow Pharmaceuticals
Argued March 30, 1993
Decided June 28, 1993
Full case nameWilliam Daubert, et ux., etc., et al., Petitioners v. Merrell Dow Pharmaceuticals, Inc.
Docket no.92-102
Citations509 U.S. 579 (more)
113 S. Ct. 2786; 125 L. Ed. 2d 469; 1993 U.S. LEXIS 4408; 61 U.S.L.W. 4805; 27 U.S.P.Q.2D (BNA) 1200; CCH Prod. Liab. Rep. ¶ 13,494; 93 Cal. Daily Op. Service 4825; 93 Daily Journal DAR 8148; 23 ELR 20979; 7 Fla. L. Weekly Fed. S 632
Case history
PriorSummary judgment granted to defendants, 727 F.Supp. 570 (S.D. Cal. 1989); affirmed, 951 F.2d 1128 (9th Cir. 1991); certiorari granted, 506 U.S. 914 (1992)
Holding
The Federal Rules of Evidence govern the admission of scientific evidence in a trial held in federal court. They require the trial judge to act as a gatekeeper before admitting the evidence, determining that the evidence is scientifically valid and relevant to the case at hand.
Court membership
Chief Justice
William Rehnquist
Associate Justices
Byron White · Harry Blackmun
John P. Stevens · Sandra Day O'Connor
Antonin Scalia · Anthony Kennedy
David Souter · Clarence Thomas
Case opinions
MajorityBlackmun, joined by White, O'Connor, Scalia, Kennedy, Souter, Thomas
Concur/dissentRehnquist, joined by Stevens
Laws applied
Federal Rules of Evidence 104(a), 702, 703
This case overturned a previous ruling or rulings
Frye v. United States (1923)

Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), is a United States Supreme Court case determining the standard for admitting expert testimony in federal courts. In Daubert, the Court held that the enactment of the Federal Rules of Evidence implicitly overturned the Frye standard; the standard that the Court articulated is referred to as the Daubert standard.[1]

  1. ^ "The Gatekeeper". Radiolab Podcasts | WNYC Studios. Retrieved July 16, 2022.